Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab in men with osteoporosis
NCT02186171Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of romosozumab in osteoporosis, sponsored by Amgen. Started Jun 2014; status: completed.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02186171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186171.